Evaluating drug behavior in cancer treatments before clinical trials
Contract Orientation & Kick Off Meeting in support of IDIQ "Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients." R&D Services
['FUNDING_OTHER'] · MAYO CLINIC ROCHESTER · NIH-10502678
This study is all about understanding how new cancer treatments work in the body, so we can make them safer and more effective for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MAYO CLINIC ROCHESTER (nih funded) |
| Locations | 1 site (ROCHESTER, UNITED STATES) |
| Trial ID | NIH-10502678 on ClinicalTrials.gov |
What this research studies
This research focuses on the preclinical evaluation of how new cancer treatment agents behave in the body, specifically looking at their pharmacokinetics and pharmacology. It involves a series of meetings to coordinate efforts among researchers and stakeholders to ensure that the evaluations are thorough and effective. Patients may benefit from this research as it aims to improve the development of new cancer therapies that are safer and more effective. The approach includes detailed assessments of how drugs are absorbed, distributed, metabolized, and excreted in the body before they are tested in humans.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are seeking new treatment options and are interested in the latest advancements in drug development.
Not a fit: Patients who are not currently undergoing treatment for cancer or those who are not interested in experimental therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and safer cancer treatments.
How similar studies have performed: Other research in preclinical pharmacokinetics has shown promise in improving drug development processes, indicating that this approach is supported by previous successes.
Where this research is happening
ROCHESTER, UNITED STATES
- MAYO CLINIC ROCHESTER — ROCHESTER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: REID, JOEL — MAYO CLINIC ROCHESTER
- Study coordinator: REID, JOEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Patient